“…In their review of the literature, Braun et al found that 35% of published cases had solitary cutaneous or subcutaneous IM [ 10 ]. Of those with a single lesion, 9% were later found to have bone, muscle, and visceral involvement, and up to 5% experienced morbidity or mortality (1%) related to extracutaneous involvement before undergoing full body screening [ 10 ]. Although there are no international published guidelines for tumor staging, various authors recommend screening patients for visceral involvement by chest X-ray, echocardiogram, and whole-body magnetic resonance imaging [ 5 , 6 , 10 ].…”